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Introduction
Pain is an unpleasant sensory and emotional experience 
associated with actual or potential tissue damage or 
described in terms of such damage.1 As such, it involves 
far more than mere sensation;2 it is a psychological state 
comprising three domains: sensory–discriminatory 
(intensity, location and duration of the pain), affective–
motivational (emotional, unpleasantness and aversive 
aspects of pain) and cognitive–evaluative (evaluation of 
consequences of pain upon quality of life [QoL]). The first 
two domains often co-vary and are usually processed 
simultaneously.3 In non-human animals the ‘sensory–dis-
criminatory’ component seems to be focused on a specific 
bodily sensation (eg, pressure, temperature, burning, etc), 
which is relatively easily provoked and investigated. By 
contrast, the unavoidable lack of self-reporting reduces 
exploration of the affective–motivational domain, which 
is usually most prominent in chronic situations,2 and 
makes exploration of the third domain even more chal-
lenging. The relationship between tissue damage and the 
reporting of pain experienced is not a simple linear corre-
lation:3 pain can occur in the absence of identifiable tissue 
damage;4 can present with confusing signs, such as 
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allodynia (sensitisation to normally innocuous stimuli); 
and can persist after the damage is resolved (persistent 
after-sensation).5 It seems that the emotional aspect has an 
important influence on the self-report of pain perception,6 
which is critical to its impact on the wellbeing of the sub-
ject experiencing the pain. In human medicine, the con-
text in which pain occurs may also affect the emotional 
reaction and perception of pain,2 with psychiatric distur-
bance and mood disorder also often present in patients 
with chronic pain.2 This highlights the importance of the 
affective–motivational domain in the assessment of pain. 
However, the lack of clear or current evidence relating to 
these features in non-human animals should not be inter-
preted as an absence of an emotional component or need 
to treat it. Instead, in order to provide effective and appro-
priate pain management for patients, it should encourage 
more research into pain assessment.
The cat is one of the most popular companion ani-
mals, with a global population estimated to be around 
600 million,7 with an estimated 69 million cats in the 
USA and 60 million in Europe.8 It is now clearly recog-
nised that vertebrates possess the neuroanatomical and 
neurophysiological components necessary for transduc-
tion, transmission and perception of noxious stimuli. 
However, it is still not clear to what degree different 
species feel pain with similar quality and intensities.9 
Despite painful situations being quite common in veteri-
nary practice, pain is still undertreated in cats.10,11 Even if 
veterinarians are becoming aware of the use of analgesia 
for pain treatment, there is an absence of approved med-
ication for some painful conditions (eg, osteoarthritis 
[OA]-associated chronic pain),12,13 as well as misconcep-
tions about analgesic drugs, and reservations about the 
adverse effects of analgesics.11 Furthermore, even though 
tools have been used to assess pain expression in cats, 
there still appears to be no consensus on when, and if, to 
use these tools, and if they really discriminate painful vs 
non-painful situations and/or different intensities and 
qualities of pain expression.14,15 The lack of agreement 
seems to stem partly from (i) the ability of cats to mask 
signs of pain, possibly as a consequence of being a 
largely solitary prey species, thus reducing potential 
predator advantage as in other species16 – their subtle 
expression of pain can easily be missed even by diligent 
observers,17 and (ii) a lack of information for cat owners 
on pain expression, which limits their ability to report 
consistent behavioural changes reliably, even if they can 
recognise these changes.18 In addition, if the behavioural 
changes develop gradually during old age, owners tend 
to consider the changes to be part of the natural ageing 
of the animal,8 and may not associate the changes with 
pain, even if they notice them.
Assessment of a patient’s experience of pain is a 
critical component of pain management, and patient 
welfare, especially in situations where the sensory aspect 
is not evident. Different tools have been used to detect 
pain in cats, but pain is not a simple construct and it 
must be recognised that simple measures do not always 
take into account the multidimensional nature of pain. A 
useful pain assessment tool should be sensitive to sev-
eral qualities of pain and ideally be able to: (i) discrimi-
nate the presence vs absence of pain; (ii) evaluate both 
the sensory and emotional aspects of the condition; (iii) 
discriminate intensity, frequency, duration and quality 
between different pain conditions (as, eg, acute vs 
chronic, mild or intermittent pain experience); (iv) eval-
uate pain in different contexts, or at least clearly state the 
contexts to which it is limited; (v) be as simple as possi-
ble, requiring minimal training and instrumentation 
(a natural observation, eg, may be the easiest method).
Furthermore, to be recommended, the different tools 
must have documented levels of validity, reliability and 
sensitivity from high quality, evidence-based studies. 
However, this information does not appear to be readily 
available, and so the aim of this report is to review the 
scientific literature systematically and critically, and syn-
thesise current knowledge in order to evaluate the 
potential utility and quality of pain assessment tools 
used in cats. Following the PRISMA guidelines for 
reporting systematic review (www.prisma-statement.
org), the review specifically aims to (i) identify the range 
of behavioural tools in use and clearly categorise how 
they have been used and the domain of pain they refer 
to; (ii) examine the behavioural metrics used to assess 
pain across tools; (iii) assess the quality of evidence relat-
ing to the use of these tools in specific contexts; and (iv) 
make recommendations for future assessment.
Materials and methods
Ethics statement
This project was approved by the University of Lincoln’s 
local ethics committee. There was no requirement to pre-
register the review protocol.
Search methods
Published reports of clinical trials evaluating pain 
expression through assessment tools in cats with differ-
ent diseases or conditions were collected through a doc-
ument search of two electronic databases – PubMed and 
ScienceDirect – using the keywords ‘Cat’ and ‘Pain’, 
and, as an additional filter, ‘other animals’. Databases 
were accessed from 15–30 February 2014. The references 
of all identified studies were inspected for additional 
papers.
Study selection
Inclusion and exclusion criteria for study selection were 
predefined to minimise the risk of bias.
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Inclusion criteria Studies had to be in English and be 
published as a peer-reviewed publication since 2000. 
They had to provide information on the assessment tool 
used to evaluate the behavioural expression of pain in 
cats; the study also had to be on conscious animals (not 
anaesthetised cats).
Exclusion criteria If the study was a narrative review, a 
comment, an abstract or a summary, had fewer than five 
participants, or fewer than five cats showing signs of 
pain, it was excluded and was not investigated for refer-
ences. If the study did not describe an assessment tool or 
did not refer to it in the results, or was referring only to 
the assessment of QoL it was also excluded. If pain was 
assessed as part of a QoL measure, only the specific data 
regarding pain were extracted.
Methodological issue in reviewing the assessment tools for 
pain We define the type of tool according to the specific 
approach used (eg, numerical rating scale [NRS], to col-
lect information about the behavioural expression of 
pain in cats. To assess pain a tool could refer to behav-
ioural changes and physiological parameters, but we 
focus in this report only on the behavioural elements. 
The subtype of a tool was the specific instrument used 
within a given type; for example, the specific form of 
NRS used. To detect the behavioural changes, metrics 
within the assessment tools refer to the specific behav-
ioural measurement used. For the metrics used, we dis-
criminated between those using objective observation to 
record a response (eg, measures such as ‘purring when 
stimulated’, ‘meows when interacting with the observer’, 
or change in activity levels, etc)19,20 and those requiring 
the observer to make an inference from their observa-
tions of the subject (eg, measures such as ‘a happy cat’, 
‘comfortable’, ‘peaceful’ or ‘cat looks miserable and can-
not be touched’, etc).21,22 The term ‘mixed’ was used 
when the scale used a combination of objective and 
interpretative metrics to differentiate different points on 
the scale (eg, pupils dilated or not, but movement con-
sidered normal or abnormal).23
The assessment tools were classified into two catego-
ries according to the domain of pain on which they were 
focused primarily: sensory and sensory–affective. The 
sensory domain is, by definition, referring to the location 
and intensity of the pain. We considered a tool to be 
focused on the sensory domain if it was referring to 
(i) a local region of the body (eg, focusing on lameness); 
(ii) an intensity scale (eg, visual analogue scale [VAS] or 
NRS related to the magnitude of pain; eg, no pain vs 
maximum pain) not providing information about pain 
characteristics and impact on the individual;24,25 (iii) a 
provoked response (eg, jumping away, paw withdrawal) 
– provocation meant any form of interaction with the 
animal (either direct human contact or instrumental 
interaction; eg, wound palpation or thermal stimula-
tion). Tools classified as referring mainly to the sensory 
domain could include some aspects of the affective com-
ponent such as inferred emotional state, but they were 
focused primarily on the sensory reaction.
All other tools were related to both sensory and affec-
tive domains; none focused primarily on the affective 
domain.
The affective domain was further classified into:
1 Emotional state – this describes the immediate 
affective response to pain and consists of four 
components:26 the communication signals issued 
in response to pain, the change in general arousal 
caused by the pain, the subsequent behavioural 
tendencies of the animal (withdrawal, avoidance 
of contact, etc) and any specific appraisal of the 
sensation linked to its emotional content (this last 
component is integrally related to the sensory 
domain).
2 Mood states – that is, enduring episodic changes 
in underlying affective predisposition arising as a 
result of a series of emotional events of congruent 
emotional valence; for example, a tendency to be 
irritable from time to time as a result of pain.
3 Temperament – that is, a general disposition or 
trait that is consistent across time and contexts. 
This indicates that the pain is persistent, or relief 
is only temporary, and that a state of pain has 
become an integral part of the animal’s constitu-
tion and its behavioural predispositions have 
shifted accordingly to adapt to the impact of this. 
For example, a cat in chronic pain might be 
described as jumpy or irritable the whole time.26
Finally, the specific behaviours assessed (metrics) 
included in the tool were also recorded.
Further data collection and evaluation
The causes of pain described and the time from when 
the pain started, together with any definition of acute or 
chronic pain, were recorded in addition to the total 
number of cats and their sex distribution. Three meas-
ures of performance were considered: validity, reliabil-
ity and sensitivity. Validity is concerned with whether 
the instrument measures the characteristic it purports to 
measure. It is often divided into content (the extent to 
which a measurement reflects the specific intended 
domain of content), construct (interpreted as a measure 
of some attribute or quality that is not ‘operationally 
defined’) and criterion validity (demonstrable agree-
ment with another measure or procedure that has been 
demonstrated to be valid).27 Reliability is concerned 
with the consistency of an instrument. It should pro-
duce the same results after re-testing, and is usually 
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divided into internal consistency (the consistency of the 
results delivered in a test, ensuring that the various 
items measuring the different constructs deliver consist-
ent scores); intra-rater (the degree of stability observed 
when a measurement is repeated under identical condi-
tions by the same rater); inter-rater (the equivalence or 
agreement among different raters who are collecting 
data); and test–retest (the degree of stability when pre-
senting the same task to the same subjects two or more 
times).28 Sensitivity is defined as the ability of the tool to 
detect any change and to identify a cut-off point on the 
scale (eg, to identify the point for rescue analgesia for 
each subject). Responsiveness (sensitivity to change) is 
an aspect of sensitivity that describes the specific ability 
of the tool to address meaningful change of clinical 
importance or relevance.29
Furthermore, the study design (experimental or 
observational) was considered. Experimental studies 
were further divided into randomised controlled trials 
(RCTs), controlled clinical trials and clinical trials, which 
were either of a ‘pre- and post-‘ design (such as pre- and 
postsurgery), or a postintervention assessment design. 
Observational studies were divided into cohort studies, 
case–control studies, cross-sectional studies and case 
series.
When assessing the quality of the instruments used to 
assess pain, the documentation of specific tests relating 
to validity, reliability and specificity were of most impor-
tance. To assess the quality of the validity of the instru-
ment, we evaluated how the authors assessed content 
validity for the tool (expert evaluation, owner records, 
etc) and for criterion validity the gold standard used 
alongside any other tools with which it showed conver-
gence. Finally, it was noted if this was undertaken as a 
blinded procedure. The rigour with which reliability and 
sensitivity were evaluated was further determined from 
the design of the study; that is, type of study, use of con-
trols and blind observers, and so on. Only RCTs with a 
negative control and a blind observer study design were 
evaluated as providing an adequate level of evidence for 
objectively assessing the reliability and sensitivity of the 
instrument.
As part of the evaluation of the usability of the test, 
the necessity to familiarise/train the cats, or to train the 
observer for each tool was also noted.
Results
Results from the search of the two databases produced 
300 papers. Of these, 12 records were duplicated and 
were eliminated. Seventy-six articles were excluded 
because they were narrative reviews; 69 were excluded 
because they had five or fewer subjects expressing signs 
of pain in the report; and 37 were excluded because they 
were not related to pain. Of the remaining 106 papers, 
43  were excluded because they did not describe an 
assessment tool or did not refer to it in the results, or 
were referring to just the assessment of QoL. This left 
63 articles, and the references cited in each of these that 
had been published since 2000 were reviewed; 37 papers 
were added to the list for the final review. One article 
was considered as two different studies because it 
included two different populations. This meant a total of 
100 articles were analysed (Figure 1).
Subject information
Cats of both sex, neutered and entire, were included 
(eight papers did not report sex information);30–37 there 
were more females (n = 2262) present in the data than 
males (n = 1125). Breed and age were not always stated, 
so it could not be assumed that all breeds and ages were 
represented.
Causes of pain
See Table S1 in the Supplementary material for references.
The causes of pain reported were as follows. Forty-
two studies were related to surgical causes: 24 to neuter-
ing;22,23,31,37–57 six to onychectomy/tenectomy;30,35,58–61 
four to neutering and onychectomy;34,62–64 three to frac-
ture repair;32,65,66 and five to a variety of other surger-
ies.21,36,67–69 One study evaluated pain during intravenous 
catheter introduction.70 Thirty-five studies were specifi-
cally designed to assess the effects of different therapies 
and/or to investigate the ability to detect pain with dif-
ferent tools (eg, thermal threshold);33,71–104 of these 35, 
six used either a kaolin injection (n = 5) or sodium urate 
injection (n = 1) to induce an inflammatory reaction as a 
cause of pain. Of the remaining 22 articles: 19 were 
related to orthopaedic situations (six degenerative joint 
disease, six OA, five lower limb musculoskeletal dis-
ease, one spondylosis and one intervertebral disc dis-
ease);8,14,15,19,20,76,104–115 one further study was related to 
otoacariasis;116 one to lower urinary tract disease;117 and 
one to upper respiratory tract disease (URTD).50
Time of presenting signs
Fifty-seven studies were related to the response to delib-
erate surgeries or provoked pain; that is, the response 
was assessed immediately after insult for a variable 
length of time. Of the remaining 22 papers, only four 
reported the time when the cat had started to express 
signs of pain.104,106,108,109 One study reported signs from 
no more than 14 days,106 describing this as ‘acute pain’, 
while another referred to pain of <8 weeks’ duration as 
acute,109 and two studies referring to chronic pain used 
subjects reporting signs for >2 months or at least 
1 month, respectively.104,108
Tool type and subtype
See Table S2 in the Supplementary material for a full list 
of references.
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Ten tool types were identified:
1 VAS, consisting of three subtypes (general VAS 
[gVAS], interactive VAS [IVAS] and dynamic 
IVAS). These are focused on providing a meas-
ure of pain intensity along a single scale; eg, no 
pain to maximal pain.30,39,44,118
2 NRS, consisting of 15 subtypes (eg, a general NRS 
similar to the gVAS but with the scale divided into 
numerical units; a simple descriptive scale where 
each number is associated with a specific definition 
[these may relate to specific facets, eg, lameness, 
response to palpation, etc, and be summed to create 
an overall score]). These scales are used in a wide 
variety of contexts with both the sensory and affec-
tive domains of pain evaluated in this way.30,32,38
3 Descriptive rating scale, consisting of four sub-
types (eg, feline musculoskeletal pain index).17,111 
In these, the rating indicates the description that 
best describes some aspect of the pain of the cat 
and this may then be allotted a score. Multi-
dimensional assessment of both the sensory and 
affective domains of pain may be undertaken 
with these scales.107,111,113
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(n =  300)
Sc
re
en
in
g
In
cl
ud
ed
El
ig
ib
ili
ty
Id
en

fic
a
on
Duplicates arcles removed
(n =  12)
Arcles screened
(n = 288)
Records excluded
(narrave reviews, less than 5 
subjects showing signs of pain and not 
related with pain)
(n = 182)
Full-text arcles assessed 
for eligibility
(n = 106)
Full-text arcles excluded 
(not in vivo studies, not assessment 
tools used for pain, or not evaluated 
in the results, different tool 
assessment, summary/comment, 
study focused on drug without pain 
assessment, or focused on
quality of life)
(n = 43)
Studies included in
qualitave synthesis
(n = 63)
100 studies included
Studies included from 
references
(n = 37)
Figure 1 Information considered at different phases of the systematic review. The number of records identified, included and 
excluded, and the reasons for exclusions, in accordance with PRISMA guidelines (www.prisma-statement.org)
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4 Thermal provocation pain tools, consisting of 
two subtypes (thermal threshold [TT] test75,81,88 
and radiant emitter mat test63,80,84). These provide 
a unidimensional measure of the sensory reac-
tion, looking at the temperature necessary to 
result in withdrawal.
5 Pressure-provoked pain tools, consisting of 11 
subtypes (eg, pressure threshold [PT] test,71,73,92,94 
mechanical nociceptive threshold tests,32,44,45 
response to orthopaedic manipulation,115 etc). 
These provide a unidimensional measure of the 
provoked sensory reaction, looking at the pres-
sure necessary to result in withdrawal.
6 Pressure measurement mat, consisting of two 
subtypes (the peak vertical force measurement105 
and pressure platform mat58,64,118). These provide 
a unidimensional measure of sensory pain in a 
local region by indicating the force being used by 
a painful limb.
7 Electric provoked pain tools (no subtypes). These 
provide a unidimensional measure of the pro-
voked sensory reaction, looking at the electricity 
necessary to result in withdrawal.94
8 Owner report (no subtypes). This is a qualitative 
report from the primary carer and may provide 
multidimensional measures of both the sensory 
and affective domain of pain.117
9 Behavioural observation (no subtypes). The fre-
quency and/or duration of certain behavioural 
measures can provide information on both the 
sensory and affective domains of pain.35,54
10 Motor activity assessment (no subtype). This 
largely provides a unidimensional measure of 
the inhibition caused by sensory pain in a local 
region.105,107,110,111
NRS scales were the most common tool, used in 
53 studies, while VAS and thermally provoked pain tools 
were used in 30, pressure-provoked pain tools in 27, a 
descriptive rating scale in 12, pressure measurement mat 
in four and activity motor in four. Behavioural observa-
tion was reported in two studies, and owner report and 
electrical threshold in only one study each (see Table S2 
in the Supplementary material).
Looking at the tool subtypes in total, 25 related primarily 
to the sensory aspect of pain (provoked reaction, local region 
and intensity), while 19 related to both sensory and affective 
domains. Only for the general NRS and simple descriptive 
scale (SDS) tool subtype were the domains investigated 
mixed (see Table S2 in the Supplementary material).
Quality of the assessment tool subtypes
Of the 100 studies explored, 25 studies were aiming to 
develop and validate a tool subtype able to assess pain in 
cats.18,20,30,33,35,38,41,43,44,54,55,58,73,74,76,77,82,95,97,101,105,110,111,113,114
Of all the tool subtypes reported, only the UNESP-
Botucatu composite pain scale,41 which refers to both the 
sensory and affective domains of pain, reported on all 
three quality measures; that is, validity, reliability and 
sensitivity (referring also to its responsiveness). The 
scale was evaluated for content, construct and criterion 
validity. All items scored higher than 0.5, in agreement 
with the expert evaluation (content); at the same time, 
good criterion validity was evaluated between blind 
observers and the gold standard; a high correlation with 
the IVAS scale (r = 0.87, P <0.001) for all blinded observ-
ers was evident (concurrent validity); and good con-
struct validity was apparent from clear hypothesis 
testing. At the same time, the tool was evaluated for 
internal consistency, and intra- and inter-rater reliability. 
Cronbach’s α coefficient for the three dimensions was 
excellent for both the subscales relating to ‘pain expres-
sion’ and ‘psychomotor change’ (r = 0.86–0.87) but indi-
cated inconsistency with physiological variables (r = 
0.28) (internal consistency); good agreement among 
blind observers was evidenced (confidence interval 
between 0.70 and 0.98 in relation to the behaviour ana-
lysed), and good agreement between the same observer 
after 1 month (inter- and intra-rater). The sensitivity and 
the specificity of the tool was >96.5%, with a cut-off 
point >7 (scale range 0–30), indicating excellent discrim-
inatory ability. The sensitivity to change (responsive-
ness) was evaluated, looking at the absolute (differences 
between pre- and post-design) and the percentage 
decrease in pain scores after analgesia had been applied 
over an extended timeframe. This tool was evaluated in 
an RCT of ovariohysterectomy with a positive control 
(fentanyl) and blind observers. Furthermore, use of the 
tool did not require the cats to be trained, or for them to 
be evaluated, and only general guidance was given to 
the pain assessors, rather than specific training.
Metrics (see Tables 1–3)
The specific behaviour measures provided for each tool 
subtypes were evaluated. For two of these subtypes, no 
information was available and these tools were excluded 
from further consideration.63,76
Metrics of the subtypes related primarily to the 
sensory component
For 12 tool subtypes related to the sensory domain that 
reported the metrics used to assess the pain, the authors 
did not specifically define the behavioural reaction to be 
measured.19,30,38,42,44,48,104,107,109,115,116,118 For the subtypes 
that reported the metrics, the behaviours principally rep-
resented were flitching/twitching of the skin, turning 
head towards stimulus/apparatus, the tendency to try 
to bite/lick the apparatus or its surface, jumping or mov-
ing away, leg/paw shake or withdrawal, and flicking of 
the tail (see Table 1 for further details). Although these 
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subtypes were focused on the sensory/appraisal domain 
(nociception of pain), the tool included few other aspects 
of the affective domain. In particular, most of them eval-
uated the vocalisation behaviour of the cats (but only 
three tool subtypes specified what type of vocalisation 
they were looking at62,70,72). Moreover, only one tool sub-
type looked at another aspect of the affective compo-
nent,105 looking at the general agitation of the subject 
(arousal) (see Table 1 for distribution of provoked reac-
tion metrics). These subtypes used objective observation 
to record a response (ie, description of the cat’s 
reaction).
Metrics of the subtypes related primarily to both 
the sensory and affective components
These metrics are reported in Tables 2 and 3. The sub-
types related to both domains were used in different con-
texts in different studies: some studies used these tools 
while observing the animal’s behaviour without interfer-
ence with the subject,8,14,19,20,35,38,50,54,55,60,64,107–111,113–115,117 
while others used them while both observing the 
natural behaviour and interacting with the sub-
ject;15,21–23,32,34,36,37,40,45,46,48,51,56,57,62,64,67,106,107,112 these tools are 
reported in separate tables (Tables 2 and 3). The metrics 
principally used (ie, in at least 11 of the 20 subtypes using 
this type of metric) relating to natural observation were 
lameness/gait/jumping, grooming, human–cat interac-
tion and overall activity, appetite/food intake and general 
mood. By contrast, the metrics principally used (ie, in at 
least 11 out of the 21 subtypes using this type of metric) 
relating to both natural and provoked observation were 
reaction to palpation/restraint, posture, vocalisations, 
body tension and general mood/behaviour. For all 41 
subtypes reporting the metrics evaluated for both 
domains, 16 used objective observation to record a respo
nse,8,19,20,34,35,38,50,50,54,60,107,109,110,113–115 12 required the 
observer to make an inference from their observa-
tion,15,21,22,36,40,45,46,56,57,62,64,67 while 12 appeared to have 
mixed categories.14,18,23,32,41,48,51,55,106,108,111,112
Discussion
In this systematic review, the range of behavioural-based 
assessment tools used to assess pain in cats was identi-
fied and evaluated. The detection of pain is one of the 
most challenging problems in medicine and biological 
studies;30 but, if not detected, pain can increase the mor-
bidity and mortality risks of the subject.30 The impor-
tance of using validated pain assessment tools has 
received more attention in recent years;120 however, in 
non-human animals the reporting of pain is always by a 
proxy and not the subject experiencing the pain, which 
adds a further level of complexity to assessing the needs 
of the patient. Thus, the validity, reliability and sensitiv-
ity of the tool used are particularly important, and it 
should be applicable in a range of contexts rather than 
related to a specific situation, although there may be at 
least three broad pathologies giving rise to pain:12 nocic-
eptive, when there is no inflammation or nervous system 
damage; inflammatory, when there is active inflamma-
tion; and neuropathic, when the nervous system is 
damaged.
Only peer-reviewed papers related to pain expression 
with in vivo experimental procedures on cats were 
selected, but still 100 papers were identified as suitable 
for inclusion. Many focused on provoked (acute) pain 
situations, such as neutering surgery or a thermal thresh-
old test, with other studies (n = 22) referring to pain in 
other contexts (of these, 17 were related to orthopaedic 
situations). By contrast, the literature relating to pain 
suggests a much wider range of conditions giving rise to 
pain. For example, diseases such as lower urinary tract 
disease, pancreatitis, inflammatory bowel disease, chol-
angiohepatitis, pleuritis, upper respiratory tract infec-
tions and obstipation have all been suggested to give rise 
to acute pain, as have conditions more broadly associ-
ated with dermatological, ocular and urogenital sys-
tems.120 Degenerative joint disease, interstitial cystitis, 
various cancers, and many dermatological, dental and 
oral diseases such as gingivostomatitis, slow healing 
wounds, burns and diabetic neuropathy have all been 
suggested as causes of chronic pain.12 However, this 
review has highlighted the limited range of conditions in 
which tools aimed at assessing pain in a structured way 
have been employed. This might be because the con-
trolled evaluation of pain may be easier in a scheduled 
condition such as a routine surgery protocol. However, 
the significance of this gap in the literature needs to be 
acknowledged as pain (nociceptive, inflammatory or 
neuropathic) arising in different circumstances may not 
only have different specific expressions, but may also be 
experientially different. Nonetheless, the basic features 
of the affective response, such as unconditioned facial 
expressions, may provide a basic platform on which this 
diversification occurs.121,122 It may be that by grounding 
development more thoroughly in such psychobiological 
processes, a more general pain assessment tool can be 
developed; at present, it seems development is often 
grounded by pragmatic requirements or assessment of 
the localised (sensory) response. In conclusion, there is 
currently no adequate pain assessment tool that has been 
shown to be valid across a wide range of situations.
This review also highlights that there does not appear 
to be a consistent definition of acute and chronic pain in 
relation to the duration of signs. The only four studies 
reporting on this (two referring to acute pain and two 
referring to chronic pain104,106,108,109) overlapped in the 
time courses they describe. Acute pain is usually 
described as a temporary feeling that has evolved to 
allow avoidance of damaging stimuli or stimuli that will 
interfere with the healing of damaged tissue;123,124 by 
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contrast, chronic pain extends beyond the expected heal-
ing period and limits activity that may exacerbate the 
damage to weakened or repaired tissue.124,125 In the lit-
erature reviewed here, the distinction between acute and 
chronic pain appears to be arbitrary, with the transition 
from acute to chronic being variously placed at a few 
days to several weeks.124 Lascelles and Robertson have 
suggested that defining pain as chronic or acute based 
on its duration fails to recognise its underlying causal 
factors;12 these authors propose that the terms ‘adaptive’ 
for acute pain and ‘maladaptive’ for chronic pain may be 
preferable, as this reflects the capacity of the body to 
avoid the stimulus. Our review indicates that all of the 
tools examining pain in a provoked situation (acute), 
such as neutering surgery, primarily focused on the sen-
sory domain of pain, while those tools examining pain in 
other conditions (more typically thought of as chronic, 
eg, degenerative situations), focused primarily on the 
affective domain. Therefore, it seems that the emotional 
aspects of pain are more widely recognised in the long-
standing context. We suggest that rather than focus on 
either the duration of pain or its putative adaptive value, 
it may be preferable to focus attention on the extent to 
which signs relate to the sensory or affective domains. 
We hypothesise that this may help not only to identify 
important qualities of pain in a more systematic way, but 
also to provide a more rational basis for different forms 
of analgesic intervention.
Ten types of assessment tools were identified: three 
referring to pain scales (VAS, NRS and descriptive rating 
scales), four referring to quantitative sensory testing (TT, 
PT, pressure mat and electric threshold), one looking at 
the owner report, one referring to the frequencies of 
behaviours and one related to the motor activity. Of 
these, the NRS, the VAS and the TT were the most repre-
sentative in all of the studies.
Few tool subtypes reported to any degree the validity, 
reliability and sensitivity for the tool. As we described 
before, an ideal assessment tool should focus on the 
aspect that needs to be detected, be highly sensitive, 
have minimal variability among observers and condi-
tions, and should not require training for the assessor 
and for the subject in which the pain is assessed. 
Following these criteria only the NRS subtype UNESP-
Botucatu scale (English version) evidenced (in an RCT 
with a positive control and blind observer) a good valid-
ity (a low internal consistency was found for the physi-
ological variables but this did not affect the tool validity), 
reliability and sensitivity (with responsiveness). This 
tool did not require the cats to be trained, with guidance 
given only to the observers that were using the tool (not 
the owner). However, there were a few limitations of this 
scale: (i) to evaluate the criterion validity the author used 
a comparative scale (IVAS) that is still not validated; (ii) 
the sensitivity/responsiveness was evaluated in an RCT 
study design but without a negative control; (iii) the tool 
has been used only in the context of ovariohysterectomy, 
with no other studies evidencing its validity in other 
pain conditions; (iv) the assessors were all persons work-
ing with animals, and no ‘non-expert’ (eg, owners) used 
the scale. These points highlight the need for further 
work on this assessment tool for it to be considered a 
valid assessment instrument of pain.
In relation to the sensory appraisal vs affective 
domains they were referring to, no tool subtypes 
described the metrics used to assess pain. When assess-
ing emotion such as pain, four distinct components 
(appraisal domain, communication, arousal and behav-
ioural tendency) need to be evaluated.26 Most tool sub-
types referred (not explicitly) only to the sensory/
appraisal aspect of pain expression and few to aspects of 
the affective components (eg, vocalisation as a form of 
emotional communication). This result reflects the lack 
of attention given to the affective domain when using a 
tool that is focusing on a provoked pain reaction (TT, PT, 
etc). Furthermore it is important to highlight that these 
tools often require substantial habituation by the cats, 
limiting the sample size and generalisation of the 
method. For these two main reasons, tools focusing only 
on the sensory domain of pain – even if reliable – cannot 
be suggested to be a general pain assessment instru-
ment, but only sensory and nociceptive pain indicators 
(eg, they might be able to detect phenomena such as 
hyperalgesia but less clearly the impact of pain on the 
animal’s wide perceptions)
Only 19 tool subtypes (in 46 studies) referred to both 
domains of pain (primarily looking at the affective com-
ponent). In 23 studies these were linked to some form of 
provocation test (eg, palpation) to assess pain, while in 
the other 23 they considered only the spontaneous 
behaviour.
Different authors are generally in accord that it 
remains important not only to observe the undisturbed 
animal, but also to interact with, move around and pal-
pate the affected area in order to complete a picture of 
how much pain the animal is in.11 Unfortunately, cat 
interaction can invoke a range of other emotional states 
in the subject, such as fear and frustration, as well as fur-
ther pain. Further damage of the tissue will elicit avoid-
ance or attack as a result of further pain, while the 
presence of the experimenter might provoke a fear of 
either pain or of the experimenter, while frustration may 
arise because the cat cannot avoid the situation and 
access a place of safety. These other emotions are impor-
tant but could complicate the assessment of pain per se if 
not considered separately. Hence, the tools requiring a 
provoked reaction for pain assessment (including the 
UNESP-Botucatu scale), even if they give more informa-
tion on the affective component of pain, compared with 
ones focused only on the sensory aspect (eg, TT), cannot 
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be suggested to meet the requirement of a global gold 
standard tool (eg, an owner cannot use these tools to 
assess pain in their cat).
A natural observation tool seems, by contrast, to be a 
better assessment tool. Behaviour is cited as one of the 
most effective and non-invasive routes by which pain 
can be assessed.126 Even if the ability to recognise behav-
ioural indicators of pain may depend on familiarity with 
the species by the assessor,127 and this assessment can be 
considered relatively subjective and to contain inherent 
bias when there is a lack of objective criteria to judge 
it,128 a well-validated pain behavioural assessment tool 
could permit an easier clinical evaluation and even an 
owner identification. In fact, owners seem able to recog-
nise behavioural changes but often do not report on 
these,18 considering sometimes the changes to be part of 
the natural ageing of the animal.8 From our results, no 
tool subtypes related to a natural observation were valid, 
reliable and sensitive. However, looking at the studies 
that used a tool subtype focused on natural observation 
(and primarily on the affective component of pain), some 
metrics were consistently identified: lameness/gait/
jumping, human–cat interaction, grooming and overall 
activity, appetite/food intake and general mood. Caution 
is required in interpreting individual indicator behav-
iours in isolation: although single behaviours may be 
suitable for simple presence/absence observations 
(as could a specific facial expression), the use of a combi-
nation of pain behaviours produces greater accuracy,129 
potentially adding information related to both pain 
domains. When considering how to infer emotion, a sys-
tematic process that should reduce the risk of error has 
recently been described for non-human animals based 
on assessing the evidence from the four components of 
emotions.130,131 This requires assessing the evidence from 
each of the following: the context leading to emotional 
arousal (appraisal), the level and form of arousal, the 
behavioural tendencies of the animal and the communi-
cative signals associated with the state (including facial 
expression). If the evidence is clearly contradictory to the 
hypothesis that the animal is in a given emotional state, 
then the inference should be rejected.
Another important observation in relation to the met-
rics used in the behavioural assessment tools is that not 
all of them used an objective description of the behav-
iours. Only 16/41 subtypes clearly used completely 
objective descriptions of behaviour rather than infer-
ence. Interpretations of behaviour require the observer 
to make an inference, which risks reducing the reliability 
and validity of the scale, and limits the generalisability 
of the results obtained with the tool. A consensus core of 
behaviours, which may be taken as reliable expressions 
of pain in cats, is only just starting to be created: for 
example Cloutier et al and Waran et al reported the fre-
quencies of some behaviours in RCT study designs with 
a negative control group.35,54 Unfortunately, this core has 
to be expanded (eg, few authors have reported on facial 
expression, while none on the behavioural tendency or 
the mood and temperament aspects of pain in cats) to 
permit an objective and systematic evaluation, by natu-
ral observation, of pain expression.
By way of further suggestions, studies should seek to: 
(i) assess pain in different conditions in high quality evi-
dence studies; (ii) discriminate between acute and chronic 
pain, not only in reference to the onset of signs, but also 
by considering the domain of pain they are referring to; 
and (iii) validate an assessment tool for the detection of 
pain in cats in both acute or chronic situations. These 
tools will have to be focused on both domains of pain 
(sensory and affective); have an objective definition for 
the metrics used; assess pain in a natural observation set-
ting; and be able to be used by owners, as well as experts. 
If a tool refers only to some aspects of pain (eg, the sen-
sory domain or only relates to acute pain), the lack of 
information on other aspects of pain (eg, the affective 
domain) needs to be explicitly acknowledged so that 
end-users do not accidentally use it in inappropriate 
contexts.
Conclusions
There is currently no adequate pain assessment tool that 
has been shown to be valid across a wide range of situa-
tions in cats. Further studies are required to provide a 
higher quality of evidence for methods used to assess pain 
in cats. Furthermore, a consistent definition for acute and 
chronic pain is needed, focusing attention on the extent to 
which signs relate to the sensory or affective domains of 
pain, rather than focusing on either the duration or its 
putative adaptive value. Tools need to be validated that 
can detect pain in a range of conditions and by different 
evaluators (veterinary surgeons and owners), which con-
sider both the sensory and emotional aspects of pain.
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